O'Neil v. Somatics, LLC

CourtDistrict Court, D. New Hampshire
DecidedSeptember 24, 2021
Docket1:20-cv-00175
StatusUnknown

This text of O'Neil v. Somatics, LLC (O'Neil v. Somatics, LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
O'Neil v. Somatics, LLC, (D.N.H. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Diane O’Neil Case No. 20-cv-175-PB v. Opinion No. 2021 DNH 151

Somatics, LLC & Elektrika, Inc.

MEMORANDUM AND ORDER In this diversity action, Diane O’Neil, a New Hampshire resident, has sued two out-of-state corporate defendants, Somatics, LLC and Elektrika, Inc., after sustaining injuries from electroconvulsive therapy with a Thymatron instrument. I allowed O’Neil to conduct jurisdictional discovery when Elektrika first moved to dismiss the claims against it for lack of personal jurisdiction. Before me is Elektrika’s renewed motion to dismiss on the same ground. Because O’Neil has failed to demonstrate that Elektrika is subject to personal jurisdiction in New Hampshire, I grant the motion to dismiss. I. BACKGROUND The Thymatron is an instrument used to treat severe psychiatric disturbances by inducing a major motor seizure through a brief but intense electrical current applied to a patient’s head in a process known as electroconvulsive therapy. From August 2016 until February 2017, O’Neil underwent multiple rounds of electroconvulsive therapy with a Thymatron at the Elliot Hospital in Manchester, New Hampshire. She allegedly suffered brain damage and permanent neurocognitive injuries as a result of that treatment.

Since its inception in the 1980s, the Thymatron has been collaboratively designed and manufactured by Elektrika, a privately held New York corporation, and Somatics, a Florida limited liability company. There is no overlap in ownership between the two companies. According to a 1997 exclusivity agreement between Elektrika and Somatics, the two “have enjoyed an exclusive and successful business relationship since 1983, characterized by close collaboration in the design, manufacture, and marketing of the Thymatron ECT device and accessories worldwide.” Doc. No. 34 at 3. In that contract, Elektrika agreed to manufacture the Thymatron exclusively for Somatics, so long as Somatics purchases at least fifty units every year. In

turn, Somatics agreed to purchase the device exclusively from Elektrika, provided that Elektrika supplies as many units as Somatics “provides good purchase orders for.” Doc. No. 34 at 3. Elektrika is the principal designer and manufacturer of the device. Elektrika designed the original Thymatron and has been responsible for design updates, with Somatics suggesting some specifications that Elektrika could reject. In terms of manufacturing, Elektrika assembles the main body of the device in New York and ships it to Somatics in Florida. Somatics completes the assembly by installing additional parts and calibrating the device. Somatics is exclusively responsible for the sale and

distribution of the Thymatron. At least since 2003, Somatics has marketed the device without any input from Elektrika. An undated agreement between the two companies regarding quality assurance practices provides that Elektrika is “responsible for handling any repairs of the Thymatrons sent to be serviced and reporting the information to Somatics who will be responsible for maintaining the repair / Customer Complaint procedures.” Doc. No. 34 at 2. Throughout the repair process, Somatics is the only entity that communicates with a Thymatron customer, such as a hospital. The process starts when a hospital contacts Somatics with a maintenance or repair request. Somatics assigns a return merchandise authorization (“RMA”)

number to the machine in question and coordinates its transfer to Elektrika. Typically, Somatics instructs the hospital to ship the device either directly to Elektrika’s New York location or to Somatics, which then forwards it to Elektrika. Upon receipt, Elektrika verifies that the machine is accompanied by an RMA issued by Somatics, examines the machine, and informs Somatics what work needs to be done. After Somatics approves the proposed repair work, Elektrika completes the repair and returns the machine. A packing slip provided by Somatics tells Elektrika where and how to ship the repaired machine, typically either back to Somatics or directly to the hospital. Somatics bills the hospital for the repair and remits payment to

Elektrika. The specific device that injured O’Neil was manufactured in 2005. Elektrika has performed maintenance or repair work on that machine on three occasions, in June 2008, January 2010, and June 2020. On each occasion, Elektrika received the machine and performed the work in New York. Elektrika then shipped it back directly to the Elliot Hospital in New Hampshire. In September 2013, Elektrika shipped a Thymatron component part directly to another hospital in New Hampshire, the Southern New Hampshire Medical Center. That hospital placed the part order with Somatics, which later remitted payment to Elektrika. Elektrika has no offices, facilities, employees, agents, or

other representatives in New Hampshire. It does, however, purchase printer cables, which are incorporated into the Thymatron, from a New Hampshire-based sales representative of a California company called Rapid Manufacturing.1 For the past ten years, Elektrika has placed via email approximately one order for 200 printer cables every year, paying around $1,000 per order.

1 The cables are used to connect the printer to the PC board in the Thymatron instrument. The complaint alleges product liability and negligence claims against Elektrika. Specifically, Elektrika is allegedly liable for a negligent failure to warn, manufacturing and design

defects, breach of the implied warranty of merchantability, and breach of the implied warranty of fitness. These theories of liability center on the idea that the Thymatron device is an inherently dangerous and defective device that was not accompanied by adequate warnings about the risks of undergoing electroconvulsive therapy. After the complaint was filed, Elektrika moved to dismiss the claims against it for lack of personal jurisdiction. O’Neil responded with a request to conduct jurisdictional discovery. I denied without prejudice Elektrika’s motion and granted O’Neil’s request for limited jurisdictional discovery after concluding that she had proffered a colorable claim that Elektrika is

subject to specific jurisdiction in New Hampshire. After the parties conducted that discovery, Elektrika renewed its motion to dismiss for lack of personal jurisdiction. I held a hearing on the motion in June 2021. At the hearing, both parties agreed that I could decide the present motion on the record before me, without conducting an evidentiary hearing. II. STANDARD OF REVIEW When defendant contests personal jurisdiction under Federal Rule of Civil Procedure 12(b)(2), plaintiff bears the burden of showing that a basis for asserting jurisdiction exists. Nandjou v. Marriott Int’l, Inc., 985 F.3d 135, 147 (1st Cir. 2021). Where, as here, the court considers a Rule 12(b)(2) motion

without holding an evidentiary hearing, the court applies the prima facie standard. See id. Under this standard, plaintiff must “proffer evidence which, taken at face value, suffices to show all facts essential to personal jurisdiction.” Baskin- Robbins Franchising LLC v. Alpenrose Dairy, Inc., 825 F.3d 28, 34 (1st Cir. 2016). In conducting this analysis, I must take the evidence offered by plaintiff as true and construe it in the light most favorable to plaintiff’s jurisdictional claim. Nandjou, 985 F.3d at 147-48. I can also consider facts offered by defendant, to the extent they are uncontradicted. A Corp. v. All Am.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
United States v. Swiss American Bank, Ltd.
274 F.3d 610 (First Circuit, 2001)
Harlow v. Children's Hospital
432 F.3d 50 (First Circuit, 2005)
Goodyear Dunlop Tires Operations, S. A. v. Brown
131 S. Ct. 2846 (Supreme Court, 2011)
Robert S. Boit v. Gar-Tec Products, Inc.
967 F.2d 671 (First Circuit, 1992)
Carreras v. PMG COLLINS, LLC
660 F.3d 549 (First Circuit, 2011)
Arthur F. Sawtelle, Etc. v. George E. Farrell
70 F.3d 1381 (First Circuit, 1995)
A Corp. v. All American Plumbing, Inc.
812 F.3d 54 (First Circuit, 2016)
Scottsdale Capital Advisors Corp. v. Deal, LLC
887 F.3d 17 (First Circuit, 2018)
Plixer International, Inc. v. Scrutinizer GMBH
905 F.3d 1 (First Circuit, 2018)
PREP Tours Inc. v. American Youth Soccer Org.
913 F.3d 11 (First Circuit, 2019)
MetalForming, Inc. v. Schechtl Maschinenbau Gmbh
914 F.3d 685 (First Circuit, 2019)
Nandjou v. Marriott Int'l, Inc.
985 F.3d 135 (First Circuit, 2021)
Ford Motor Co. v. Montana Eighth Judicial Dist.
592 U.S. 351 (Supreme Court, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
O'Neil v. Somatics, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/oneil-v-somatics-llc-nhd-2021.